AGP Picks
View all

Get your fresh news on health and wellness in New Hampshire

Provided by AGP

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 4, 2026

Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
Emerging Drugs Market to Reach $558.0 Billion by 2030, Driven by Biologics Innovation and Regulatory Support
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
Entente Education Canada honours Dr. Roger Wong with Award for Eminent Contribution to Older Adults in Canada
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
Cartesian Therapeutics Announces New Employment Inducement Grants
NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output
Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Indivior Announces $175 Million Accelerated Share Repurchase
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

Share us

on your social networks:

Sign up for:

New Hampshire Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.